Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Van Dedem

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biotechnology and Bioengineering|March 1, 1973
Cell growth and extracellular enzyme synthesis in fermentationsG Van Dedem, M Moo-Young
Biotechnology and Bioengineering|September 1, 1975
A model for diauxic growthG Van Dedem, M Moo-Young
Thrombosis Research|June 1, 1981
Biophysical characteristics of anionic density-fractionated mucosal heparins in relation to potencies in anticoagulant and thrombin-inhibition assaysR E Hurst, G van Dedem, J M Settine
Biotechnology and Bioengineering Symposium|January 1, 1979
Process modeling based on biochemical mechanisms of microbial growthA R Moreira, G van Dedem, M Moo-Young
Thrombosis Research|August 1, 1982
A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: a survey of its pharmacological properties in experimental animal modelsD G Meuleman, P M Hobbelen, G van Dedem, et al.
The Journal of Infectious Diseases|February 1, 1990
Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activityM Baba, E De Clercq, D Schols, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biotechnology and Bioengineering|March 1, 1973
Cell growth and extracellular enzyme synthesis in fermentationsG Van Dedem, M Moo-Young
Biotechnology and Bioengineering|September 1, 1975
A model for diauxic growthG Van Dedem, M Moo-Young
Thrombosis Research|June 1, 1981
Biophysical characteristics of anionic density-fractionated mucosal heparins in relation to potencies in anticoagulant and thrombin-inhibition assaysR E Hurst, G van Dedem, J M Settine
Biotechnology and Bioengineering Symposium|January 1, 1979
Process modeling based on biochemical mechanisms of microbial growthA R Moreira, G van Dedem, M Moo-Young
Thrombosis Research|August 1, 1982
A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: a survey of its pharmacological properties in experimental animal modelsD G Meuleman, P M Hobbelen, G van Dedem, et al.
The Journal of Infectious Diseases|February 1, 1990
Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activityM Baba, E De Clercq, D Schols, et al.
Pageof 1